Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic cancer
Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic cancer
Characteristics associated with longer-term OS with NALIRIFOX regimen in metastatic pancreatic adenocarcinoma
Gemcitabine/nab-paclitaxel compared with 5-fluorouracil/leucovorin/liposomal irinotecan shows similar results in older patients
Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study
Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours
Selecting patients wisely for neoadjuvant therapy in HPB cancers
TACE combined with lenvatinib-pembrolizumab shows improved PFS in intermediate stage liver cancer
Assessment of suicide risk in cancer patients
Association of adult attachment with delays in accessing specialist care in women with ovarian cancer
Cancer journeys: Research from India
Depression in cancer
Managing 'fear of recurrence' of cancer patients